Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Healthcare ETF

72.38
+0.36000.50%
Post-market: 72.380.00000.00%19:30 EDT
Volume:3.32M
Turnover:240.07M
Market Cap:3.89B
PE:6.52
High:73.21
Open:72.93
Low:72.14
Close:72.02
52wk High:74.59
52wk Low:56.44
Shares:53.70M
Float Shares:53.70M
Volume Ratio:9.40
T/O Rate:6.18%
Dividend:0.81
Dividend Rate:1.12%
EPS(TTM):11.10
EPS(LYR):3.06
ROE:6.01%
ROA:0.87%
PB:1.39
PE(LYR):23.66

Loading ...

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

Lobe Sciences Names David Kideckel CFO as Mirza Rahimani Shifts to VP Finance

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Bernstein Issues a Buy Rating on UnitedHealth (UNH)

TIPRANKS
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

Envoy Medical Appoints Robert Potashnick Chief Accounting Officer, VP Finance

Reuters
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Aug 28

UnitedHealth downgraded to Hold from Buy at Erste Group

TIPRANKS
·
Aug 27

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Aug 27

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Aug 27

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Aug 27

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27